Cimpress Q2 Earnings Call Highlights

1 month ago 33

MarketBeat

Thu, January 29, 2026 astatine 11:11 AM CST 7 min read

Cimpress logo

For the archetypal clip Cimpress reported quarterly gross supra $1 billion (Q2 up 11% reported, 4% organic) and raised its fiscal 2026 guidance to 7%–8% gross maturation with astatine slightest $79 million nett income and $460 million adjusted EBITDA.
Growth astatine Vista was driven by “elevated” categories—promotional products, apparel/gifts, and packaging—while absorption highlighted a 9% year‑over‑year summation successful adaptable gross nett per lawsuit arsenic grounds of rising wallet stock among small-business clients.
Cimpress is prioritizing deleveraging and selective superior deployment: nett leverage fell to 2.97x contempt >$25 cardinal successful buybacks, Cross‑Cimpress Fulfillment (XCF) volumes doubled to >$80 cardinal H1 FY26 (adding ~$15 million gross nett successful FY25), and absorption reiterated fiscal 2028 targets including ≥$600 million adjusted EBITDA and nett leverage beneath 2.0x.
Interested successful Cimpress plc? Here are 5 stocks we similar better.

3 Industrials Stocks Standing Out for Growth and Analyst Optimism

Cimpress (NASDAQ:CMPR) executives highlighted grounds quarterly revenue, improving maturation trends successful cardinal “elevated” merchandise categories, and a higher full-year outlook during the company’s fiscal 2026 second-quarter net follow-up call. Founder, Chairman and CEO Robert Keane and CFO Sean Quinn said the institution is tracking up of its archetypal fiscal 2026 expectations and reiterated assurance successful longer-term fiscal 2028 profitability and deleveraging targets.

Quinn said the 2nd 4th marked the archetypal clip Cimpress exceeded $1 cardinal successful quarterly revenue. For Q2, gross accrued 11% connected a reported ground and 4% connected an integrated constant-currency basis, with maturation crossed each segments. Through the archetypal half, Cimpress delivered 4% integrated constant-currency gross growth, which Quinn said was up of the company’s anterior full-year integrated maturation guidance scope of 2% to 3%.

→ Trump Triggers Buying Opportunity successful UnitedHealth Group

On the backmost of the first-half performance, Cimpress raised its fiscal 2026 outlook. The institution present expects:

Revenue growth of 7% to 8%, including 3% to 4% integrated constant-currency growth
Net income of astatine slightest $79 million
Adjusted EBITDA of astatine slightest $460 million (up from astatine slightest $450 million)
Operating currency flow of astir $313 million
Adjusted escaped currency flow of astir $145 million (up from $140 million)

Quinn said the reported maturation complaint included benefits from currency and a tuck-in acquisition successful the PrintBrothers segment. He added that the company’s year-over-year adjusted EBITDA maturation successful the archetypal fractional matched the full-year dollar maturation implied successful anterior guidance, which supported raising the EBITDA outlook.